77 related articles for article (PubMed ID: 15217533)
1. Epidermal growth factor receptor as a target to improve treatment of lung cancer.
Andratschke NH; Dittmann KH; Mason KA; Fan Z; Liao Z; Komaki R; Ang KK; Milas L
Clin Lung Cancer; 2004 May; 5(6):340-52. PubMed ID: 15217533
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Raben D; Helfrich B; Bunn PA
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
[TBL] [Abstract][Full Text] [Related]
3. New molecular targeted therapies integrated with radiation therapy in lung cancer.
Provencio M; Sánchez A; Garrido P; Valcárcel F
Clin Lung Cancer; 2010 Mar; 11(2):91-7. PubMed ID: 20199974
[TBL] [Abstract][Full Text] [Related]
4. Ongoing first-line studies of epidermal growth factor receptor tyrosine kinase inhibitors in select patient populations.
Jänne PA
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S9-15. PubMed ID: 16459174
[TBL] [Abstract][Full Text] [Related]
5. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for cetuximab in non small cell lung cancer?
Morgensztern D; Govindan R
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4602-5. PubMed ID: 17671149
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.
Agelaki S; Georgoulias V
Expert Opin Emerg Drugs; 2005 Nov; 10(4):855-74. PubMed ID: 16262567
[TBL] [Abstract][Full Text] [Related]
8. An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancer.
Edelman MJ
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S3-8. PubMed ID: 16459173
[TBL] [Abstract][Full Text] [Related]
9. Potential role for epidermal growth factor receptor inhibitors in combined-modality therapy for non-small-cell lung cancer.
Kim DW; Choy H
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):11-20. PubMed ID: 15142630
[TBL] [Abstract][Full Text] [Related]
10. Integration of EGFR inhibitors and conventional chemotherapy in the treatment of non-small-cell lung cancer.
Pennell NA
Clin Lung Cancer; 2011 Nov; 12(6):350-9. PubMed ID: 21723791
[TBL] [Abstract][Full Text] [Related]
11. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
Langer C; Soria JC
Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor as a target in cancer therapy.
Kim ES
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S87-95. PubMed ID: 19795581
[TBL] [Abstract][Full Text] [Related]
13. Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors.
Bonomi PD; Buckingham L; Coon J
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4606-12. PubMed ID: 17671150
[TBL] [Abstract][Full Text] [Related]
14. Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go.
Patel JD; Pasche B; Argiris A
Crit Rev Oncol Hematol; 2004 Jun; 50(3):175-86. PubMed ID: 15182824
[TBL] [Abstract][Full Text] [Related]
15. Metastatic non-small cell lung cancer management: novel targets and recent clinical advances.
Riess JW; Wakelee HA
Clin Adv Hematol Oncol; 2012 Apr; 10(4):226-34. PubMed ID: 22706483
[TBL] [Abstract][Full Text] [Related]
16. New treatment strategies in patients with advanced non-small-cell lung cancer and performance status 2.
Rodriguez E; Lilenbaum RC
Clin Lung Cancer; 2008 Nov; 9(6):326-30. PubMed ID: 19073514
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeted agents in non-small-cell lung cancer.
Sandler AB
Clin Lung Cancer; 2003 Sep; 5 Suppl 1():S22-8. PubMed ID: 14641991
[TBL] [Abstract][Full Text] [Related]
18. [New therapies for non-small cell lung cancer].
Ostoros G; Kovács G; Szondy K; Döme B
Orv Hetil; 2005 May; 146(21):1135-41. PubMed ID: 15991677
[TBL] [Abstract][Full Text] [Related]
19. The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer.
Hong L; Han Y; Brain L
Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):111-7. PubMed ID: 24410474
[TBL] [Abstract][Full Text] [Related]
20. A systems pharmacology approach to improve drug therapy in NSCLC: establishing a CESAR network.
Kalayda GV; Michaelis M; Cinatl J; Mader RM; Fröhlich H; Sarin N; Melin J; Engel F; Jäger W; Frötschl R; Jaehde U; Kloft C; Ritter CA
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):89-91. PubMed ID: 24216144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
